248 related articles for article (PubMed ID: 12528987)
1. Lipids as a target for drugs modulating multidrug resistance of cancer cells.
Hendrich AB; Michalak K
Curr Drug Targets; 2003 Jan; 4(1):23-30. PubMed ID: 12528987
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
Pérez-Tomás R
Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
[TBL] [Abstract][Full Text] [Related]
3. Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets.
Kopecka J; Trouillas P; Gašparović AČ; Gazzano E; Assaraf YG; Riganti C
Drug Resist Updat; 2020 Mar; 49():100670. PubMed ID: 31846838
[TBL] [Abstract][Full Text] [Related]
4. Lipid regulation of the ABCB1 and ABCG2 multidrug transporters.
Hegedüs C; Telbisz Á; Hegedűs T; Sarkadi B; Özvegy-Laczka C
Adv Cancer Res; 2015; 125():97-137. PubMed ID: 25640268
[TBL] [Abstract][Full Text] [Related]
5. MDR reversal and pro-apoptotic effects of statins and statins combined with flavonoids in colon cancer cells.
Palko-Łabuz A; Środa-Pomianek K; Wesołowska O; Kostrzewa-Susłow E; Uryga A; Michalak K
Biomed Pharmacother; 2019 Jan; 109():1511-1522. PubMed ID: 30551403
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability.
Drori S; Eytan GD; Assaraf YG
Eur J Biochem; 1995 Mar; 228(3):1020-9. PubMed ID: 7737146
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
Barrand MA; Bagrij T; Neo SY
Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane.
Ferté J
Eur J Biochem; 2000 Jan; 267(2):277-94. PubMed ID: 10632698
[TBL] [Abstract][Full Text] [Related]
9. New phenothiazine-type multidrug resistance modifiers: anti-MDR activity versus membrane perturbing potency.
Hendrich AB; Wesołowska O; Motohashi N; Molnár J; Michalak K
Biochem Biophys Res Commun; 2003 May; 304(2):260-5. PubMed ID: 12711308
[TBL] [Abstract][Full Text] [Related]
10. Modulation of P-glycoprotein (PGP) mediated multidrug resistance (MDR) using chemosensitizers: recent advances in the design of selective MDR modulators.
Krishna R; Mayer LD
Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):163-74. PubMed ID: 12678765
[TBL] [Abstract][Full Text] [Related]
11. The P-glycoprotein multidrug transporter: interactions with membrane lipids, and their modulation of activity.
Sharom FJ
Biochem Soc Trans; 1997 Aug; 25(3):1088-96. PubMed ID: 9388605
[No Abstract] [Full Text] [Related]
12. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.
Di Pietro A; Dayan G; Conseil G; Steinfels E; Krell T; Trompier D; Baubichon-Cortay H; Jault J
Braz J Med Biol Res; 1999 Aug; 32(8):925-39. PubMed ID: 10454753
[TBL] [Abstract][Full Text] [Related]
14. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).
Sharom FJ
Biochem Cell Biol; 2006 Dec; 84(6):979-92. PubMed ID: 17215884
[TBL] [Abstract][Full Text] [Related]
15. Marine Natural Products as Models to Circumvent Multidrug Resistance.
Long S; Sousa E; Kijjoa A; Pinto MM
Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665
[TBL] [Abstract][Full Text] [Related]
16. Interactions of phenothiazines with lipid bilayer and their role in multidrug resistance reversal.
Michalak K; Wesolowska O; Motohashi N; Molnar J; Hendrich AB
Curr Drug Targets; 2006 Sep; 7(9):1095-105. PubMed ID: 17017888
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functions.
Vijayaraghavalu S; Peetla C; Lu S; Labhasetwar V
Mol Pharm; 2012 Sep; 9(9):2730-42. PubMed ID: 22817326
[TBL] [Abstract][Full Text] [Related]
18. Multidrug Resistance Proteins (MRPs) and Cancer Therapy.
Zhang YK; Wang YJ; Gupta P; Chen ZS
AAPS J; 2015 Jul; 17(4):802-12. PubMed ID: 25840885
[TBL] [Abstract][Full Text] [Related]
19. Drug resistance-associated changes in sphingolipids and ABC transporters occur in different regions of membrane domains.
Hinrichs JW; Klappe K; van Riezen M; Kok JW
J Lipid Res; 2005 Nov; 46(11):2367-76. PubMed ID: 16150833
[TBL] [Abstract][Full Text] [Related]
20. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade.
Kathawala RJ; Gupta P; Ashby CR; Chen ZS
Drug Resist Updat; 2015 Jan; 18():1-17. PubMed ID: 25554624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
